| Metric | შპს მეგაბა | შპს ვიტ ჯორჯია ფარმი | შპს კულა სკ | შპს მედ ფარმასი გრუპი | შპს მონოპოლი |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue | ₾4.5m₾2.7m | ₾743k₾753k | ₾5.2m₾0 | ₾2.1m₾1.6m | ₾967k₾2.8m |
| Revenue growth | 67.4% | -1.4% | — | 27.3% | -65.5% |
| Profitability | |||||
| EBITDA | ₾250k₾212k | ₾172k₾139k | -₾289k₾0 | ₾476k₾235k | ₾23k₾196k |
| EBITDA margin | 5.6%7.9% | 23.2%18.5% | -5.5% | 22.7%14.3% | 2.4%7.0% |
| Net profit | ₾219k₾176k | ₾39k₾59k | -₾235k₾0 | ₾357k₾139k | -₾10k₾164k |
| Net margin | 4.9%6.6% | 5.3%7.9% | -4.5% | 17.1%8.4% | -1.0%5.9% |
| Balance sheet | |||||
| Total assets | ₾1.5m₾1.3m | ₾1.7m₾1.8m | ₾2.6m₾444k | ₾2.1m₾1.9m | ₾1.9m₾2.0m |
| Total equity | ₾1.3m₾1.1m | ₾13k₾61k | -₾209k₾26k | ₾1.8m₾1.4m | ₾726k₾736k |
| ROE | 16.9%16.3% | 310.6%96.7% | —0.0% | 20.0%9.7% | -1.4%22.3% |